Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer
Joseph, N., Dovedi, S. J., Thompson, C., Lyons, J., Kennedy, J., Elliott, T., West, C. M., Choudhury, A.Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv546
Date:
November, 2015
File:
PDF, 685 KB
english, 2015